FDA clears first DNA-based blood test for cystic fibrosis
This article was originally published in Clinica
Executive Summary
The US FDA has cleared for sale in the US the first DNA-based blood test for cystic fibrosis (CF). The Tag-It Cystic Fibrosis kit - developed by Toronto, Ontario-based Tm Bioscience - is used to help diagnose cystic fibrosis in children and identify adult genetic carriers of gene variants that are associated with the hereditary disorder.